Comparing redo surgery and stereotactic radiosurgery for recurrent, residual, and/or tumors showing progression in nonfunctioning pituitary adenomas: A systematic review and meta-analysis

CONCLUSION: Redo surgery is the superior choice in the treatment of recurrent/residual or progressing NFPAs if the tumor size is large and an immediate reduction in tumor burden through debulking is warranted. However, redo surgery is associated with a higher risk of visual loss, new endocrinopathies, and other complications, in contrast to SRS.PMID:38468659 | PMC:PMC10927195 | DOI:10.25259/SNI_907_2023

Source: Surgical Neurology International - March 12, 2024 Category: Neurosurgery Authors: Muhammad Yousuf Ul Islam Saad Akhtar Roua Nasir Saad Bin Anis Haissan Iftikhar Farhan Raza Khan Russell Seth Martins Muhammad Ehsan Bari Urooba Ahmed Source Type: research